Cannabinoid-based products submitted by consumers experiencing adverse effects were analyzed to identify and quantitate ingredients.
Product testing identified several synthetic cannabinoids and products with inaccurate or incomplete labeling. (Publisher Abstract)
Downloads
Similar Publications
- New Nitazene Analogue N-Pyrrolidino Protonitazene Impacting Drug Markets In North America and Europe
- Minimizing inhibition of PCR-STR typing using digital agarose droplet microfluidics
- Emergency department-based testing for xylazine and other novel psychoactive substances in Central Alabama: a feasibility study